Cell Culture Media Market

Cell culture media Market Size

Cell Culture Media Market size was valued at USD 3.5 billion in 2023 and is expected to grow at a CAGR of 12.8% between 2024 and 2032, driven by factors such as the rising global prevalence of chronic disease such as cancer, diabetes, autoimmune disease that fuels the demand for cell-based research therapies.

Also, the ongoing advancements in cell culture technologies, such as the development of serum-free and chemically defined media formulations, have improved the efficiency, reproducibility, and scalability of cell culture. For instance, in July 2023, Lonza launched the TheraPRO CHO Media System, a new cell culture platform that simplifies processes and optimizes productivity and protein quality when used with GS-CHO cell lines. Therefore, these advancements drive the adoption of cell culture media in both research including regenerative medicine and industrial applications which is anticipated to accelerate the market growth.

Cell culture media, also known as growth media, is an umbrella term that encompasses any gel or liquid created to support cellular growth in an artificial environment. It is the medium that supplies the nutrients necessary for cell cultures to survive and proliferate. The growth media also provides the correct osmolality and pH.

Cell culture media Market Trends

• The rising demand of biologicals due to their effectiveness in treating various diseases such as cancer, autoimmune disorders, and infectious diseases increases the demand for cell culture media as most of the biopharmaceutical companies heavily rely on cell culture media to produce biologics, including monoclonal antibodies, vaccines, and recombinant proteins. For instance, in February 2022, Nucleus Biologics launched Krakatoa, an innovative, first-to-market media maker that allows researchers to manufacture cell culture media at point of use. Such product launch associated with cell culture media is expected to impel market growth.
  
• Moreover, the increase in shift toward personalized medicine and cell-based therapies where treatments are tailored to individual patients based on their genetic makeup, lifestyle, and environmental factors, boosts the demand for cell culture media, thereby augmenting the market growth.
  

Cell culture media Market Analysis

Based on the product type, the global market is classified into serum-free media, specialty media, chemically defined media, stem cell culture media and other product type. The serum-free media segment dominated the market with revenue of USD 1.2 billion in 2023.

• The various advantages offered by serum-free media such as less risk of contamination in cell culture and high growth & productivity are driving the demand for serum-free media cell culture.
  
• Furthermore, the diverse utilization of serum-free media in biopharmaceutical manufacturing, tissue engineering, and regenerative medicine is on rise, leading to an increased demand for customized serum-free media, thereby supplementing the segmental growth.
  

Based on the application, the global cell culture media market is classified into biopharmaceutical production, diagnostics, drug screening and development, tissue engineering & regenerative medicine, research purpose, and other applications. The biopharmaceutical production segment dominated the market with market share of 36.6% in 2023.

• The increasing demand for biopharmaceuticals owing to growing demand for personalized medicine drives the need for biopharmaceuticals, leading to increased production activities. Also, continuous advancements in biotechnology, including genetic engineering techniques and cell culture technologies, enable the production of complex biopharmaceuticals, necessitating advanced cell culture media for optimal cell growth and production.
  

Based on end-user, the cell culture media market is classified into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end-users. Pharmaceutical and biotechnology companies’ segment is expected to exhibit 13.4% CAGR between 2024 - 2032.

• The rising investment in R&D activities by pharmaceutical and biotechnology firms aimed at developing and advancing novel therapeutic products, coupled with the escalating need for cell culture media, underlines the vital role of cell cultures in the research and development continuum. These cultures facilitate drug candidate screening, biologics production for preclinical and clinical investigations, and the refinement of manufacturing procedures.
  
• Furthermore, the growing importance of cell culture media in cultivating patient-derived cells and tissues for endeavors like cell therapy and regenerative medicine is prompting substantial investments from biopharmaceutical companies.
  

In 2023, North America secured a substantial market share of 42.7% in the global cell culture media market and is expected to dominate throughout the forecast period.

• The factors such as significant investment in research and development, presence of key players, and collaborations between pharmaceutical & biopharmaceutical companies, research institutions, and CROs are driving the adoption of cell culture media in their development stages, thereby fostering the regional market growth.
  
• In addition, government initiatives and funding for biomedical research and biotechnology innovation provide additional impetus to the growth of the market.
  

Cell culture media Market Share

The competitive landscape of the cell culture media industry is characterized by the presence of established players vying for market share. Key players are engaging in strategic initiatives such as acquisitions, product launch, investment, and partnerships to strengthen their product portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective cell culture media.

Cell culture media Market Companies

Prominent players operating in the cell culture media industry are as mentioned below:

• ACROBiosystems
• Corning Incorporation
• Danaher Corporation
• FUJIFILM Irvine Scientific
• Lonza Group
• Merck KGaA
• Miltenyi Biotech
• Nuvonis
• Sartorius AG
• ScienCell Research Laboratories
• Thermo Fisher Scientific Inc.
  

Cell culture media Industry News:

• In April 2023, AnaBios completed the acquisition of Cell Systems, a human primary and cell culture media provider. The acquisition aimed to expand Anabios portfolio of human tissue and cells, thereby strengthening its product pipeline.
  
• In July 2023, Merck announced the expansion of its cell culture media production with investment of more than USD 22 million in Kansas, U.S. This strategy is expected enhance company to outreach to untapped economies.
  

The cell culture media market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Serum-free media
  • CHO media
  • HEK 293 media
  • BHK media
  • VERO cell media
  • Insect cell media
  • Immune cell media
  • Other serum-free media
• Specialty media
• Chemically defined media
• Stem cell culture media
• Other product types

Market, By Application

• Biopharmaceutical production
  • Monoclonal antibodies
  • Vaccine production
  • Other biopharmaceutical productions
• Diagnostics
• Drug screening and development
• Tissue engineering & regenerative medicine
• Research purpose
• Other applications

Market, By End-user

• Pharmaceutical and biotechnology companies
• Hospitals and diagnostic laboratories
• Research and academic institutes
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudia Arabia
  • Rest of Middle East and Africa